PharmTech Drug Digest 11.20
News|Articles|August 1, 2004

Pharmaceutical Technology

  • Pharmaceutical Technology-08-01-2004
  • Volume 2004 Supplement
  • Issue 5

2004 Outsourcing Survey: Growing Demand for Services and Performance

Author(s)Jim Miller

Data from the 2004 Outsourcing Survey indicate that pharmaceutical companies are spending more on outsourced drug development, but with fewer suppliers.


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.